Communicating risk: Does scientific debate compromise safety?

A NEW APPROACH IN FAILURE MODES AND EFFECTS ANALYSIS BASED ON COMPROMISE SOLUTION BY CONSIDERING OBJECTIVE AND SUBJECTIVE WEIGHTS WITH INTERVAL-VALUED INTUITIONISTIC FUZZY SETS

Failure modes and effects analysis (FMEA) is a well-known risk analysis approach that has been conducted to distinguish, analyze and mitigate serious failure modes. It demonstrates the effectiveness and the ability of understanding and documenting in a clear manner; however, the FMEA has weak points and it has been criticized by some authors. For example, it does not consider relative importanc...

The Debate Over Compromise and the Goals of the Judicial Process

Talmudic literature documents a sharp debate among the tannaim regarding the legitimacy of the process of compromise or, to be more precise, of the process of bitsu‘a. This dispute appears in a well-known passage in Tosefta Sanhedrin, chapter 1, and in both Talmuds (y.Sanh. 1:1 [18b], b.Sanh. 6b), and is also mentioned briefly in Sifre Deuteronomy §17. Even upon first glance it can be seen that...

Ethics of Communicating Scientific Findings of Autism Risk CONFERENCE MATERIALS Ethics of Communicating Scientific Findings of Autism Risk CASES

The real and perceived risks of genetically modified organisms.

The debate about the various risks of genetically modified organisms (GMOs) has been with us for almost a lifetime, ever since a voluntary moratorium on some recombinant DNA research was declared in Asilomar, California, in 1975. Whereas the original concerns centred on the risks of GM technology in general, in recent years it has shifted to GM crops and food. Whenever an application to release...

Clinical Translation of Tissue Engineered Medicinal Products

Tissue Engineering is a rapidly growing field with novel scientific concepts, new technological methods, and evolving regulatory policies for clinical translation. Most of the current basic regulations are taken from the pharma, bio-pharma, cell therapy with little modifications, and new inclusion for development of regulatory frame work for advanced therapeutic products. We propose to highligh...